drugset / Trial / NCT03588351

Chitosan,Chitosan Nanoparticles,and Chlorhexidine Gluconate, as Intra Canal Medicaments in Primary Teeth

NCT03588351

Unknown 45 enrolled Ain Shams University
RandomizedParallel-groupDouble-blindTreatment

Summary

Aim of the present study is to assess the in vivo susceptibility of root canal bacteria to Chitosan,Chitosan nanoparticles ,and Chlorhexidine gluconate when used as intra canal medicaments in necrotic primary molars

Timeline

Start
2018-01-01
Primary completion
2018-08-15
Completion
2018-08-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Chlorhexidine gluconate Other / unclassified Other
Subject POLIGLUSAM Other / unclassified Other
Subject chitosan nanoparticles Other / unclassified Other

Indications